Incidence of multiple sclerosis in the United Kingdom: Findings from a population-based cohort

Journal of Neurology

Volumn 254, Issue 12, 2007, Pages 1736-1741

  Alonso, A ^a   Jick, S S ^b   Olek, M J ^c   Hernan M A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Incidence; Multiple sclerosis; Population based; Prospective studies

Indexed keywords

ADULT; AGED; ARTICLE; DATA BASE; DISEASE COURSE; FEMALE; GENERAL PRACTICE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RISK FACTOR; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY HEALTH PLANNING; CONFIDENCE INTERVALS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS;

EID: 37749046386     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-007-0602-z     Document Type: Article

References (34)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938-952
2. Zivadinov R, Iona L, Monti-Bragadin L, et al. (2003) The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. Neuroepidemiology 22:65-74
3. Pugliatti M, Rosati G, Carton H, et al. (2006) The epidemiology of multiple sclerosis in Europe. Eur J Neurol 13:700-722
4. Villard-Mackintosh L,Vessey MP (1993) Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47:161-168
5. Thorogood M, Hannaford PC (1998) The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 105:1296-1299
6. Murray S, Bashir K, Penrice G, Womersley J (2004) Epidemiology of multiple sclerosis in Glasgow. Scott Med J 49:100-104
7. Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302:766-768
8. Jick SS, Kaye JA,Vasilakis-Scaramozza C, et al. (2003) Validity of the General Practice Research Database. Pharmacotherapy 23:686-689
9. Hollowell J (1997) The General Practice Research Database: quality of morbidity data. Popul Trends 87:36-40
10. Poser CM, Paty DW, Scheinberg L, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
11. McDonald WI, Compston A, Edan G, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
12. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M (2002) Age standardization of rates: a new WHO standard. GPE Discussion Paper Series No. 31.World Health Organization, Geneva
13. Rothman KJ,Greenland S (1998) Measures of disease frequency. In: Rothman KJ,Greenland S (eds) Modern Epidemiology. Lippincott Williams and Wilkins, Philadelphia, pp 29-46
14. Statistical Research and Applications Branch - National Cancer Institute. DevCan: Probability of Developing or Dying of Cancer Software (computer program). Version 5.3; 2004
15. Fay MP, Pfeiffer R, Cronin KA, Le C, Feuer EJ (2003) Age-conditional probabilities of developing cancer. Stat Med 22:1837-1848
16. Fay MP (2004) Estimating age conditional probability of developing disease from surveillance data. Popul Health Metr 2:6
17. Office for National Statistics (2003) Series DH1 No. 34. Mortality statistics general. Review of the Registrar General on deaths in England and Wales, 2001. Office for National Statistics, London, UK
18. McDonnell GV,Hawkins SA (2002) Primary progressive multiple sclerosis: increasing clarity but many unanswered questions. J Neurol Sci 199:1-15
19. Midgard R, Riise T, Svanes C,Kvale G, Nyland H (1996) Incidence of multiple sclerosis in More and Romsdal,Norway from 1950 to 1991. An age-periodcohort analysis. Brain 119:203-211
20. Koch-Henriksen N (1999) The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler 5:293-296
21. Sundstrom P,Nystrom L, Forsgren L (2003) Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden. J Neurol Neurosurg Psychiatr 74:29-32
22. Sarasoja T,Wikstrom J, Palmataa J, Hakama M, Sumelahti ML (2004) Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years. Acta Neurol Scand 110:331-336
23. Hennessy A, Swingler RJ, Compston DA (1989) The incidence and mortality of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatr 52:1085-1089
24. Mumford CJ, Fraser MB,Wood NW, Compston DA (1992) Multiple sclerosis in the Cambridge health district of east Anglia. J Neurol Neurosurg Psychiatr 55:877-882
25. Robertson N, Deans J, Fraser M, Compston DA (1996) Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register. J Epidemiol Community Health 50:274-279
26. Rothwell PM, Charlton D (1998) High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatr 64:730-735
27. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD (2000) The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123:665-676
28. Ford HL,Gerry E, Johnson M,Williams R (2002) A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. J Neurol 249:260-265
29. Tremlett H, Paty D, Devonshire V (2005) The natural history of primary progressive multiple sclerosis in British Columbia, Canada. Neurology 65:1919-1923
30. Granieri E, Malagu S, Casetta I, et al. (1996) Multiple sclerosis in Italy.A reappraisal of incidence and prevalence in Ferrara. Arch Neurol 53:793-798
31. Barnett MH, Williams DB, Day S, Macaskill P, McLeod JG (2003) Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci 213:1-6
32. Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R (2004) Multiple sclerosis in Nord-Trondelag County,Norway: a prevalence and incidence study. Acta Neurol Scand 109:378-384
33. Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr KM (2006) A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 66:182-186
34. Pugliatti M, Riise T, Sotgiu MA, et al. (2005) Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology 25:129-134